Antenatal Intracellular Concentrations of Tenofovir Diphosphate and Emtricitabine Triphosphate and Associations Between Tenofovir Diphosphate and Severe Adverse Pregnancy Outcomes: IMPAACT-PROMISE (1077BF) Trial
Jim Aizire(MUJHU Research Collaboration), Mae Cababasay(Cancer Research And Biostatistics), Kevin Butler(Cancer Research And Biostatistics), Terry Fenton(Harvard University), Kristina M. Brooks(National Institutes of Health Clinical Center), George K. Siberry(Columbia University Irving Medical Center), Jennifer J. Kiser, Mary Glenn Fowler(Johns Hopkins University), Patricia M. Flynn(St. Jude Children's Research Hospital), Mark Mirochnick(Boston University)
Cited by 6
Related Papers
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2009|3.6k
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
|The Lancet|1999|1.7k
Maternal Viral Load, Zidovudine Treatment, and the Risk of Transmission of Human Immunodeficiency Virus Type 1 from Mother to Infant
|New England Journal of Medicine|1996|817
Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection
|Clinical Infectious Diseases|2018|728
MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs
|Nature Medicine|1999|580